Opsy Holding

Opsy Holding OCF Margin

The Operating Cash Flow Margin of Opsy Holding (OPSYH.SL) as of Oct 29, 2026 is -98.76 %. In the previous year, Operating Cash Flow Margin was 154.44 % — a change of -163.95% (lower).

OCF Margin

-98.76 %

YoY

-163.95%

Last updated:

Operating Cash Flow Margin of Opsy Holding is 2025 -98.76 % . Operating Cash Flow Margin of Opsy Holding was 2024 154.44 % . It decreases by -163.95% lower compared to the previous year.

The Opsy Holding OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2014
-91.03 SEK
Jan 1, 2024
154.44 SEK
Jan 1, 2025
-98.76 SEK
The Opsy Holding OCF Margin history
YEAROCF MarginYoY
-98.76 %-163.95%
154.44 %-269.66%
-91.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Opsy Holding Stock analysis

What does Opsy Holding do? Opsy Holding AB develops a software platform for insurance companies and medical advisors, focusing on anti-metastatic therapies related to the Wnt-5a protein. The company's products target the metastatic process through specific small molecules that interact with Wnt-5a mechanisms. Insurance companies and medical advisors purchase the platform to integrate advanced therapeutic insights into their services. The company's primary market segment consists of healthcare technology providers seeking innovative solutions for metastasis research. Opsy Holding AB's software platform is designed to support medical advisors and insurance firms in evaluating small molecules that specifically interact with the Wnt-5a protein's role in metastasis. The company's focus on Wnt-5a mechanisms positions its products for specialized healthcare applications. Insurance companies use the platform to enhance their risk assessment models with advanced therapeutic data. The company's business model centers on providing a technology platform that bridges medical research and insurance applications. By targeting the Wnt-5a protein's role in metastasis, Opsy Holding AB offers a niche solution for healthcare technology providers. The platform's value lies in its ability to connect specific small molecule evaluations with practical applications in insurance and medical advisory services. Opsy Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Opsy Holding stock

Operating Cash Flow Margin of Opsy Holding is -98.76 % in 2025.

Operating Cash Flow Margin of Opsy Holding changed from 154.44 % to -98.76 %, representing a -163.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Opsy Holding since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Opsy Holding with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Opsy Holding

All Key Metrics — Opsy Holding